Case Report: Neuropsychiatric instability in structurally compromised CNS Erdheim–Chester disease: a diagnostic and management challenge

Background: Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis involving multiple systems, with central nervous system (CNS) involvement present in a significant subset. Neuropsychiatric symptoms such as cognitive decline, mood disturbances, and psychosis have been documented. However, sensitivity to psychotropic medications in CNS-involved ECD remains underreported. This case highlights a multi-mechanistically compromised CNS posing diagnostic and therapeutic challenges by such sensitivity. Case presentation: A 50-year-old woman with biopsy-confirmed ECD and CNS involvement presented with persistent neuropsychiatric symptom confusion, psychosis, cognitive decline, mood lability, and agitation despite radiologic remission following cladribine and radiotherapy. She exhibited marked sensitivity to multiple psychotropics: haloperidol induced QTc prolongation; risperidone and aripiprazole triggered akathisia and insomnia; olanzapine caused hypotension; chlorpromazine and quetiapine led to oversedation; and benzodiazepines paradoxically worsened agitation. Only valproic acid was tolerated. Factors such as previous chemotherapy, brain radiotherapy, hypernatremia, endocrine dysfunction, and a family history of psychiatric illness were suspected to have a role in predisposition. Imaging showed lesions of the hypothalamus, pituitary stalk, and mesial temporal lobes. Persistent symptoms shared features with Lewy Body Dementia and raised the diagnostic ambiguity. Conclusion: To our knowledge, this is one of the first detailed reports to describe heightened neuropsychiatric instability and psychotropic intolerance in a patient with a compromised CNS through several suspected mechanisms. The case underscores the need for multidisciplinary care and cautious psychiatric management in patients with a compromised CNS. Clinicians should suspect psychotropic sensitivity in cases with paradoxical responses and consider systemic causes such as ECD as a possible contributor.

Authors

Institutions

Publication Details

Journal
Frontiers in Psychiatry
Published
2026-04-13
DOI
https://doi.org/10.3389/fpsyt.2026.1752665
Primary Topic
Histiocytic Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Report: Neuropsychiatric instability in structurally compromised CNS Erdheim–Chester disease: a diagnostic and management challenge

Abdulaziz F. Alfraiji, Fahad D. Alosaimi, Shahad Aljudi, Mohamed F. Alqahtani
Frontiers in Psychiatry
Histiocytic Disorders and Treatments
article

Case Report: Neuropsychiatric instability in structurally compromised CNS Erdheim–Chester disease: a diagnostic and management challenge

Abdulaziz F. Alfraiji, Fahad D. Alosaimi, Shahad Aljudi, Mohamed F. Alqahtani
article en

Abstract

Background: Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis involving multiple systems, with central nervous system (CNS) involvement present in a significant subset. Neuropsychiatric symptoms such as cognitive decline, mood disturbances, and psychosis have been documented. However, sensitivity to psychotropic medications in CNS-involved ECD remains underreported. This case highlights a multi-mechanistically compromised CNS posing diagnostic and therapeutic challenges by such sensitivity. Case presentation: A 50-year-old woman with biopsy-confirmed ECD and CNS involvement presented with persistent neuropsychiatric symptom confusion, psychosis, cognitive decline, mood lability, and agitation despite radiologic remission following cladribine and radiotherapy. She exhibited marked sensitivity to multiple psychotropics: haloperidol induced QTc prolongation; risperidone and aripiprazole triggered akathisia and insomnia; olanzapine caused hypotension; chlorpromazine and quetiapine led to oversedation; and benzodiazepines paradoxically worsened agitation. Only valproic acid was tolerated. Factors such as previous chemotherapy, brain radiotherapy, hypernatremia, endocrine dysfunction, and a family history of psychiatric illness were suspected to have a role in predisposition. Imaging showed lesions of the hypothalamus, pituitary stalk, and mesial temporal lobes. Persistent symptoms shared features with Lewy Body Dementia and raised the diagnostic ambiguity. Conclusion: To our knowledge, this is one of the first detailed reports to describe heightened neuropsychiatric instability and psychotropic intolerance in a patient with a compromised CNS through several suspected mechanisms. The case underscores the need for multidisciplinary care and cautious psychiatric management in patients with a compromised CNS. Clinicians should suspect psychotropic sensitivity in cases with paradoxical responses and consider systemic causes such as ECD as a possible contributor.

Frontiers in PsychiatryVol. 17
King Saud University (SA)
Gender equality
Openalex Percentile: Top 25%
Histiocytic Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.